Stephanie Amiel is Professor of Diabetes Research at King’s College London and consultant physician at King’s College Hospital in the UK. She trained at Guy’s Hospital, London with Harry Keen, and started her research career at Yale with Robert Sherwin and Bill Tamborlane. She was instrumental in developing the UK’s structured education programme around flexible insulin therapy for adults with type 1 diabetes (DAFNE) and islet transplantation as a treatment for hypoglycaemia in the UK. She has researched the pathogenesis and treatment of impaired awareness of hypoglycaemia. She is currently running a JDRF-funded trial of a novel intervention to prevent hypoglycaemia and is involved in the EU-IMI project HypoRESOLVE. She chaired the management of type 1 diabetes in adults guideline for the UK’s NICE and has contributed to international guidelines and consensus statements in hypoglycaemia and the use of CGM.